Detalhe da pesquisa
1.
Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population.
Hered Cancer Clin Pract
; 20(1): 1, 2022 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34983599
2.
Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland.
Hered Cancer Clin Pract
; 20(1): 13, 2022 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395863
3.
Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population.
Hered Cancer Clin Pract
; 19(1): 6, 2021 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33419454
4.
Bladder cancer survival in patients with NOD2 or CDKN2A variants.
Oncotarget
; 13: 628-640, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35478773
5.
Survival of bladder or renal cancer in patients with CHEK2 mutations.
PLoS One
; 16(9): e0257132, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34499690
6.
CHEK2 Alleles Predispose to Renal Cancer in Poland.
JAMA Oncol
; 5(4): 576, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30816943
7.
Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population.
PLoS One
; 6(9): e25057, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21966413
8.
Selenium as marker for cancer risk and prevention.
Pol Przegl Chir
; 84(9): 470-5, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23241574